Published in J Mol Cell Cardiol on March 28, 2010
Advances in targeting cyclic nucleotide phosphodiesterases. Nat Rev Drug Discov (2014) 1.86
Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments. Br J Pharmacol (2012) 1.26
Phosphodiesterase 4B in the cardiac L-type Ca²⁺ channel complex regulates Ca²⁺ current and protects against ventricular arrhythmias in mice. J Clin Invest (2011) 1.09
Compartmentalization of beta-adrenergic signals in cardiomyocytes. Circ Res (2011) 1.07
Phosphodiesterase 4D regulates baseline sarcoplasmic reticulum Ca2+ release and cardiac contractility, independently of L-type Ca2+ current. Circ Res (2011) 0.96
Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart. Circ Res (2012) 0.95
Distinct patterns of constitutive phosphodiesterase activity in mouse sinoatrial node and atrial myocardium. PLoS One (2012) 0.94
Phosphodiesterase-8A binds to and regulates Raf-1 kinase. Proc Natl Acad Sci U S A (2013) 0.93
Cyclic AMP synthesis and hydrolysis in the normal and failing heart. Pflugers Arch (2014) 0.89
Clinical and molecular genetics of the phosphodiesterases (PDEs). Endocr Rev (2013) 0.89
cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis. Mol Pharmacol (2012) 0.88
Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications. J Cardiovasc Transl Res (2010) 0.85
Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects. Horm Metab Res (2012) 0.84
Regulation of adrenal steroidogenesis by the high-affinity phosphodiesterase 8 family. Horm Metab Res (2012) 0.84
Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment. Curr Opin Pharmacol (2011) 0.82
Therapeutic potential of PDE modulation in treating heart disease. Future Med Chem (2013) 0.80
PDE4B mediates local feedback regulation of β₁-adrenergic cAMP signaling in a sarcolemmal compartment of cardiac myocytes. J Cell Sci (2014) 0.79
Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes. Cardiovasc Res (2013) 0.79
A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse Leydig cells via PDE8 and PDE4 inhibition. PLoS One (2013) 0.78
Genomewide Association Study of African Children Identifies Association of SCHIP1 and PDE8A with Facial Size and Shape. PLoS Genet (2016) 0.78
Cardiac cAMP: production, hydrolysis, modulation and detection. Front Pharmacol (2015) 0.77
Molecular inotropy mediated by cardiac miR-based PDE4D/PRKAR1α/phosphoprotein signaling. Sci Rep (2016) 0.75
In permanent atrial fibrillation, PDE3 reduces force responses to 5-HT, but PDE3 and PDE4 do not cause the blunting of atrial arrhythmias. Br J Pharmacol (2016) 0.75
Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol (2008) 6.19
Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem (2007) 5.62
Amplitude distribution of calcium sparks in confocal images: theory and studies with an automatic detection method. Biophys J (1999) 3.83
Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am J Physiol Heart Circ Physiol (2000) 3.32
Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res (2006) 2.59
Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci U S A (1998) 2.00
Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease. Cardiovasc Drugs Ther (2007) 1.76
Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. J Physiol (1997) 1.73
Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem (1998) 1.72
Calcium sparks in intact skeletal muscle fibers of the frog. J Gen Physiol (2001) 1.65
Functional coupling of calcineurin and protein kinase A in mouse ventricular myocytes. J Physiol (2002) 1.54
Phosphodiesterases and compartmentalized cAMP signalling in the heart. Eur J Cell Biol (2006) 1.30
Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A. Proc Natl Acad Sci U S A (2006) 1.23
Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels. Cardiovasc Res (2005) 1.13
Foxp3-dependent programme of regulatory T-cell differentiation. Nature (2007) 9.48
Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev (2006) 6.75
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res (2011) 2.99
Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation (2009) 2.96
Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol (2006) 2.58
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol (2011) 2.40
Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res (2003) 2.39
Constitutively active L-type Ca2+ channels. Proc Natl Acad Sci U S A (2005) 2.24
The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding. Proc Natl Acad Sci U S A (2002) 2.10
Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells. Am J Physiol Cell Physiol (2009) 1.93
Mechanisms underlying heterogeneous Ca2+ sparklet activity in arterial smooth muscle. J Gen Physiol (2006) 1.86
Cyclic nucleotide analogs as probes of signaling pathways. Nat Methods (2008) 1.84
Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest (2003) 1.79
Phosphodiesterase type 5: expanding roles in cardiovascular regulation. Circ Res (2007) 1.74
AKAP150 is required for stuttering persistent Ca2+ sparklets and angiotensin II-induced hypertension. Circ Res (2008) 1.72
Differential calcineurin/NFATc3 activity contributes to the Ito transmural gradient in the mouse heart. Circ Res (2006) 1.64
Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res (2010) 1.59
AKAP150 contributes to enhanced vascular tone by facilitating large-conductance Ca2+-activated K+ channel remodeling in hyperglycemia and diabetes mellitus. Circ Res (2013) 1.59
Activation of NFATc3 down-regulates the beta1 subunit of large conductance, calcium-activated K+ channels in arterial smooth muscle and contributes to hypertension. J Biol Chem (2006) 1.58
PDE5 is converted to an activated state upon cGMP binding to the GAF A domain. EMBO J (2003) 1.56
Alterations in early action potential repolarization causes localized failure of sarcoplasmic reticulum Ca2+ release. Circ Res (2005) 1.55
Increased coupled gating of L-type Ca2+ channels during hypertension and Timothy syndrome. Circ Res (2010) 1.55
Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (2010) 1.48
Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy. Circ Res (2009) 1.47
Crystal structure of the tandem GAF domains from a cyanobacterial adenylyl cyclase: modes of ligand binding and dimerization. Proc Natl Acad Sci U S A (2005) 1.40
NFATc3 regulates Kv2.1 expression in arterial smooth muscle. J Biol Chem (2004) 1.39
Calcium sparklets regulate local and global calcium in murine arterial smooth muscle. J Physiol (2006) 1.39
The control of Ca2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension. Proc Natl Acad Sci U S A (2008) 1.38
Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS One (2009) 1.36
Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells. J Biol Chem (2001) 1.35
Hydrolysis products of cAMP analogs cause transformation of Trypanosoma brucei from slender to stumpy-like forms. Proc Natl Acad Sci U S A (2006) 1.34
Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes. Proc Natl Acad Sci U S A (2010) 1.33
Kv2 channels oppose myogenic constriction of rat cerebral arteries. Am J Physiol Cell Physiol (2006) 1.32
GAF domains: two-billion-year-old molecular switches that bind cyclic nucleotides. Mol Interv (2002) 1.29
Ca(v)1.3 channels produce persistent calcium sparklets, but Ca(v)1.2 channels are responsible for sparklets in mouse arterial smooth muscle. Am J Physiol Heart Circ Physiol (2007) 1.28
An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria. Proc Natl Acad Sci U S A (2011) 1.27
Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3. Circ Res (2007) 1.27
Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy. J Pathol (2012) 1.26
Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A. Proc Natl Acad Sci U S A (2006) 1.23
Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling. J Physiol (2009) 1.19
mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain. J Comp Neurol (2003) 1.17
Restoration of normal L-type Ca2+ channel function during Timothy syndrome by ablation of an anchoring protein. Circ Res (2011) 1.16
Molecular determinants of cGMP binding to chicken cone photoreceptor phosphodiesterase. J Biol Chem (2004) 1.16
The structure of the GAF A domain from phosphodiesterase 6C reveals determinants of cGMP binding, a conserved binding surface, and a large cGMP-dependent conformational change. J Biol Chem (2008) 1.15
Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation. Circ Res (2002) 1.15
Ca2+ signaling amplification by oligomerization of L-type Cav1.2 channels. Proc Natl Acad Sci U S A (2012) 1.14
The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland. Mol Pharmacol (2010) 1.13
Mechanisms underlying variations in excitation-contraction coupling across the mouse left ventricular free wall. J Physiol (2006) 1.12
Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A. J Biol Chem (2004) 1.12
Local control of TRPV4 channels by AKAP150-targeted PKC in arterial smooth muscle. J Gen Physiol (2014) 1.10
Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells. J Immunol (2003) 1.06
Knockout of Na+/Ca2+ exchanger in smooth muscle attenuates vasoconstriction and L-type Ca2+ channel current and lowers blood pressure. Am J Physiol Heart Circ Physiol (2010) 1.05
Differentiation of human monocytes in vitro with granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor produces distinct changes in cGMP phosphodiesterase expression. Cell Signal (2004) 1.03
Microtubule-mediated defects in junctophilin-2 trafficking contribute to myocyte transverse-tubule remodeling and Ca2+ handling dysfunction in heart failure. Circulation (2014) 1.02
A-kinase anchoring proteins interact with phosphodiesterases in T lymphocyte cell lines. J Immunol (2004) 1.01
Solution structure of the cGMP binding GAF domain from phosphodiesterase 5: insights into nucleotide specificity, dimerization, and cGMP-dependent conformational change. J Biol Chem (2008) 1.01
Cyclic nucleotide signaling mechanisms in trypanosomes: possible targets for therapeutic agents. Mol Interv (2007) 1.00
Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages. Proc Natl Acad Sci U S A (2009) 1.00
NFATc3-dependent loss of I(to) gradient across the left ventricular wall during chronic beta adrenergic stimulation. J Mol Cell Cardiol (2008) 1.00
Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from Trypanosoma brucei. Proc Natl Acad Sci U S A (2002) 1.00
Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages. Neurochem Int (2004) 0.97
A-kinase anchoring proteins: getting to the heart of the matter. Circulation (2010) 0.97
The GAFa domains of rod cGMP-phosphodiesterase 6 determine the selectivity of the enzyme dimerization. J Biol Chem (2003) 0.97
Eosinophil cysteinyl leukotriene synthesis mediated by exogenous secreted phospholipase A2 group X. J Biol Chem (2010) 0.95
Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation. J Neurosci (2003) 0.94
Trypanosome cyclic nucleotide phosphodiesterase 2B binds cAMP through its GAF-A domain. J Biol Chem (2004) 0.93
Phosphodiesterase-8A binds to and regulates Raf-1 kinase. Proc Natl Acad Sci U S A (2013) 0.93
The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis. Curr Opin Pharmacol (2011) 0.91
Cyclic nucleotide specific phosphodiesterases of the kinetoplastida: a unified nomenclature. Mol Biochem Parasitol (2005) 0.91
Single cell transcriptional profiling of adult mouse cardiomyocytes. J Vis Exp (2011) 0.91
The cyanobacterial tandem GAF domains from the cyaB2 adenylyl cyclase signal via both cAMP-binding sites. Proc Natl Acad Sci U S A (2005) 0.90
Selective up-regulation of PDE1B2 upon monocyte-to-macrophage differentiation. Proc Natl Acad Sci U S A (2004) 0.90
Relationship between Ca2+ sparklets and sarcoplasmic reticulum Ca2+ load and release in rat cerebral arterial smooth muscle. Am J Physiol Heart Circ Physiol (2011) 0.89
cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis. Mol Pharmacol (2012) 0.88
Kaempferia parviflora, a plant used in traditional medicine to enhance sexual performance contains large amounts of low affinity PDE5 inhibitors. J Ethnopharmacol (2011) 0.87
NFAT-dependent excitation-transcription coupling in heart. Circ Res (2008) 0.85
Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophy. Handb Exp Pharmacol (2011) 0.84
Dynamic changes in sarcoplasmic reticulum structure in ventricular myocytes. J Biomed Biotechnol (2011) 0.83
PDE1B2 regulates cGMP and a subset of the phenotypic characteristics acquired upon macrophage differentiation from a monocyte. Proc Natl Acad Sci U S A (2006) 0.83
Cardiomyocyte-specific expression of lamin a improves cardiac function in Lmna-/- mice. PLoS One (2012) 0.81
L-type Ca2+ channel function during Timothy syndrome. Trends Cardiovasc Med (2012) 0.81
Enzyme assays for cGMP hydrolyzing phosphodiesterases. Methods Mol Biol (2013) 0.80
Cyclic nucleotides and phosphodiesterases in monocytic differentiation. Handb Exp Pharmacol (2011) 0.79
PDE3 and PDE4 isozyme-selective inhibitors are both required for synergistic activation of brown adipose tissue. Mol Pharmacol (2013) 0.79
A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse Leydig cells via PDE8 and PDE4 inhibition. PLoS One (2013) 0.78
On the loose: uncaging Ca2+ -induced Ca2+ release in smooth muscle. J Gen Physiol (2006) 0.78
Identification of a new variant of PDE1A calmodulin-stimulated cyclic nucleotide phosphodiesterase expressed in mouse sperm. Biol Reprod (2005) 0.78
Regulation of endothelial barrier function by cyclic nucleotides: the role of phosphodiesterases. Handb Exp Pharmacol (2011) 0.78
CaV1.2 sparklets in heart and vascular smooth muscle. J Mol Cell Cardiol (2012) 0.78
A Ca2+- and PKC-driven regulatory network in airway smooth muscle. J Gen Physiol (2013) 0.78
Regulation of L-type calcium channel sparklet activity by c-Src and PKC-α. Am J Physiol Cell Physiol (2013) 0.77
Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi. Biochem J (2006) 0.77
How does the shape of the cardiac action potential control calcium signaling and contraction in the heart? J Mol Cell Cardiol (2010) 0.76
Adding accessories for hypertension: α2δ-1 subunits upregulate CaV1.2 channels in arterial myocytes in a model of genetic hypertension. Hypertension (2012) 0.75